Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
Food Sci Biotechnol ; 31(9): 1145-1155, 2022 Aug.
Article in English | MEDLINE | ID: mdl-35919362

ABSTRACT

Oat contains a variety of phenolic compounds, including avenanthramides, which are found only in oats. This study was conducted to establish the quantitative analysis of seven phenolic compounds in oat powders and sprouted oat powders and validate an efficient high-performance liquid chromatography (HPLC) method. All calibration curves represented good linearity (R 2 ≥ 0.9997) in the concentration range (0.5-50 mg/kg) with LOD and LOQ of 0.01-0.21 and 0.02-0.64 mg/kg, respectively. Intra-day accuracy (%) and precision (%RSD) were 90.7-103.8% and 1.5-4.9%, respectively. Inter-day accuracy (%) and precision (%RSD) were 90.4-107.9% and 2.2-4.8%, respectively. Moreover, relative expanded measurement uncertainty results complied with CODEX guideline. In addition, selected oat and sprouted oat powder extracts showed anti-microbial activities against Escherichia coli O157:H7. These results demonstrated that this HPLC method is suitable for the qualification and quantification of seven phenolic compounds in oat and sprouted oat. Supplementary Information: The online version contains supplementary material available at 10.1007/s10068-022-01099-8.

2.
J Dairy Sci ; 105(3): 1900-1912, 2022 Mar.
Article in English | MEDLINE | ID: mdl-35086699

ABSTRACT

The aim of the present study was to investigate the antiinflammatory and antibiofilm effects of whey fermented by Enterococcus faecalis M157 (M157-W) against oral pathogenic bacteria. The M157-W significantly inhibited IL-1ß, IL-6, and nitric oxide induced by the lipopolysaccharide of Porphyromonas gingivalis in RAW 264.7 cells. The M157-W also inhibited the production of IL-1ß and IL-8 in human periodontal ligament cells. Treatment with M157-W suppressed the phosphorylation of mitogen-activated protein kinases as well as the activation of nuclear factor-κB in RAW 264.7 cells stimulated by P. gingivalis lipopolysaccharide. Furthermore, M157-W dose-dependently inhibited Streptococcus mutans biofilm, whereas unfermented whey did not inhibit the biofilm. Treatment with M157-W significantly suppressed gtfB, gtfC, and gtfD gene expression in S. mutans compared with the control (0 µg/mL), indicating that M157-W inhibits S. mutans biofilm formation by reducing the synthesis of extracellular polymeric substances. Collectively, these results suggest that M157-W has antiinflammatory and antibiofilm activities against oral pathogenic bacteria.


Subject(s)
Enterococcus faecalis , Whey , Animals , Biofilms , Lipopolysaccharides/pharmacology , Streptococcus mutans/genetics
3.
J Dairy Sci ; 104(4): 3876-3887, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33612219

ABSTRACT

Biotransformation, the structural modification of chemical compounds, has proved to be an indispensable tool in providing beneficial health effects. Although the health benefits of biotransformation using plant sources has been widely studied, the anti-adipogenic effect of biotransformed dairy products, such as whey, have not yet been demonstrated. Here, we investigated the anti-adipogenic effect of whey biotransformed by Weissella cibaria in 3T3-L1 adipocytes. Weissella cibaria-biotransformed whey considerably reduced the accumulation of lipid droplets and intracellular triglycerides in 3T3-L1 cells. In the presence of W. cibaria-biotransformed whey, the mRNA and protein expression of a key transcription factor, peroxisome proliferator-activated receptor γ (PPARγ), for adipogenesis was markedly suppressed in 3T3-L1 cells. Additionally, W. cibaria-biotransformed whey also decreased the mRNA and protein expressions of lipoprotein lipase and adipocyte fatty acid-binding protein, which are regulated by PPARγ. Moreover, W. cibaria-biotransformed whey inhibited the expression of adipokines, resistin, and leptin. Collectively, these results suggest that whey biotransformed by W. cibaria has the potential to exert anti-adipogenic effects by inhibiting intracellular signaling events of adipogenic-related transcription factors and target genes.


Subject(s)
Adipogenesis , Whey , 3T3-L1 Cells , Adipocytes/metabolism , Animals , Biotransformation , Cell Differentiation , Mice , PPAR gamma/genetics , PPAR gamma/metabolism , Weissella , Whey/metabolism
4.
Int J Nanomedicine ; 13: 7217-7227, 2018.
Article in English | MEDLINE | ID: mdl-30510414

ABSTRACT

BACKGROUND: Tendon-derived stem cells (TDSCs) are key factors associated with regeneration and healing in tendinopathy. The aim of this study was to investigate the effects of mechanical stiffness and topographic signals on the differentiation of TDSCs depending on age and pathological conditions. MATERIALS AND METHODS: We compared TDSCs extracted from normal tendon tissues with TDSCs from tendinopathic Achilles tendon tissues of Sprague Dawley rats in vitro and TDSCs cultured on nanotopographic cues and substrate stiffness to determine how to control the TDSCs. The tendinopathy model was created using a chemical induction method, and the tendon injury model was created via an injury-and-overuse method. Norland Optical Adhesive 86 (NOA86) substrate with 2.48 GPa stiffness with and without 800 nm-wide nanogrooves and a polyurethane substrate with 800 nm-wide nanogrooves were used. RESULTS: TDSCs from 5-week-old normal tendon showed high expression of type III collagen on the flat NOA86 substrate. In the 15-week normal tendon model, expression of type III collagen was high in TDSCs cultured on the 800 nm NOA86 substrates. However, in the 15-week tendon injury model, expression of type III collagen was similar irrespective of nanotopographic cues or substrate stiffness. The expression of type I collagen was also independent of nanotopographic cues and substrate stiffness in the 15-week normal and tendon injury models. Gene expression of scleraxis was increased in TDSCs cultured on the flat NOA86 substrate in the 5-week normal tendon model (P=0.001). In the 15-week normal tendon model, scleraxis was highly expressed in TDSCs cultured on the 800 nm and flat NOA86 substrate (P=0.043). However, this gene expression was not significantly different between the substrates in the 5-week tendinopathy and 15-week tendon injury models. CONCLUSION: Development and maturation of tendon are enhanced when TDSCs from normal tendons were cultured on stiff surface, but not when the TDSCs came from pathologic models. Therapeutic applications of TDSCs need to be flexible based on tendon age and tendinopathy.


Subject(s)
Achilles Tendon/pathology , Nanoparticles/chemistry , Stem Cells/cytology , Animals , Basic Helix-Loop-Helix Transcription Factors/genetics , Basic Helix-Loop-Helix Transcription Factors/metabolism , Biomechanical Phenomena , Cell Differentiation/drug effects , Collagen Type I/metabolism , Collagen Type III/metabolism , Cues , Gene Expression Regulation , Male , Rats , Rats, Sprague-Dawley , Tendon Injuries/genetics , Tendon Injuries/pathology , Wound Healing
5.
PLoS One ; 13(3): e0194288, 2018.
Article in English | MEDLINE | ID: mdl-29534084

ABSTRACT

Osteoarthritis (OA) is characterized by a progressive loss of articular cartilage, subchondral bone sclerosis and synovial inflammation and is the most common chronic condition worldwide today. However, most treatments have focused on pain relief and OA symptoms. For these reasons, many ongoing studies are currently trying to develop efficient and successful therapies based on its pathology. Animal models that mimic the histopathology and symptoms of OA have a critical role in OA research and make it possible to investigate both secondary osteoarthritic changes due to a precedent event such as traumatic injury and naturally occurring changes for the development of therapeutics which can be tested in preclinical and clinical OA trials. We induced OA in various animal models including rats, rabbits and guinea pigs by chemical, surgical and naturally occurring methods. In particular, the Dunkin-Hartley guinea pig is very attractive as an OA animal model because OA slowly progresses which is similar to human primary OA. Thus, this animal model mimics the pathophysiological process and environment of human primary OA. Besides the spontaneous OA model, anterior cruciate ligament transection (ACLT) with medial meniscectomy and bilateral ovariectomy (OVX) as well as a chemical technique using sodium monoiodoacetate (MIA) were used to induce OA. We found that ACLT in the rat model induced OA changes in the histology and micro-CT image compared to OVX. The osteoarthritic change significantly increased following ACLT surgery in the rabbit model. Furthermore, we identified that OA pathogenic changes occurred in a time-dependent manner in spontaneous Dunkin-Hartley guinea pigs. The MIA injection model is a rapid and minimally invasive method for inducing OA in animal models, whereas the spontaneous OA model has a slow and gradual progression of OA similar to human primary OA. We observed that histological OA change was extraordinarily increased at 9 ½ months in the spontaneous OA model, and thus, the grade was similar with that of the MIA model. Therefore, this study reports on OA pathology using various animal models as well as the spontaneous results naturally occurring in an OA animal model which had developed cartilage lesions and progressive osteoarthritic changes.


Subject(s)
Cartilage, Articular/pathology , Disease Models, Animal , Osteoarthritis/pathology , Tissue Engineering/methods , Animals , Anterior Cruciate Ligament/surgery , Female , Guinea Pigs , Humans , Iodoacetic Acid/toxicity , Meniscectomy , Menisci, Tibial/surgery , Osteoarthritis/diagnostic imaging , Osteoarthritis/etiology , Osteoarthritis/therapy , Ovariectomy , Rabbits , Rats , Rats, Sprague-Dawley , Time Factors , X-Ray Microtomography
6.
J Cell Physiol ; 233(8): 6196-6206, 2018 08.
Article in English | MEDLINE | ID: mdl-29341108

ABSTRACT

Tendon derived stem cells (TDSCs) have been used as a therapeutic agent and as a healing marker. However, there has been no study about the characteristics of TDSCs extracted from tendinopathic tendon tissues. The aim of this study was to find the different characteristics of TDSCs according to the factors to induce the tendinopathy. Five- and fifteen-week old Sprague Dawley rats were used for this study and chemically-induced and injury-induced tendinopathy models were made depending on the age of the animal for different types of tendinopathy. TDSCs from chemically-induced tendinopathy showed markedly low proliferation compared to those from age-matched normal control and injury-induced tendinopathy. In addition, TDSCs from chemically-induced tendinopathy progressed to osteogenesis under an osteogenic differentiation environment more than those from other groups. In contrast, TDSCs from injury-induced tendinopathy showed markedly high proliferation and high expression of type III collagen and α-SMA compared to other groups. Adipogenic potentials in TDSCs from injury-induced tendinopathy were also higher. These different characteristics might be helpful in the development new therapeutic agents for tendon regeneration according to different factors to induce the tendinopathy.


Subject(s)
Stem Cells/cytology , Tendinopathy/pathology , Tendons/cytology , Actins/metabolism , Animals , Cell Differentiation/physiology , Cell Proliferation/physiology , Collagen Type III/metabolism , Osteogenesis/physiology , Rats , Rats, Sprague-Dawley , Regeneration/physiology , Stem Cells/metabolism , Tendinopathy/metabolism , Tendons/metabolism , Wound Healing/physiology
7.
Lasers Med Sci ; 31(2): 289-96, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26714983

ABSTRACT

The aim of the present study was to investigate the therapeutic mechanism of low-level laser therapy (LLLT) in the mouse tail lymphedema model. Six-week-old female mice were classified into the laser treatment group, sham treatment group, and surgical control group (10 mice per group). LLLT was administered daily for 10 min from the surgical day to 11 days (12 times). Macrophage activation and lymphatic vessel regeneration were evaluated through immunohistochemical staining with anti-F4/80 and anti-LYVE-1 antibodies, respectively, at 12 days post-procedure. Quantitative real-time polymerase chain reaction (qPCR) was performed to measure messenger RNA (mRNA) expression of vascular endothelial growth factor A, B, C, R1, R2, and R3 (VEGF-A, VEGF-B, VEGF-C, VEGFR1, VEGFR2, and VEGFR3) at 12 days post-procedure. Student's t and one-way ANOVA tests were performed for statistical analyses. Significance was defined as p < 0.05. The thickness of the tail rapidly increased until 6 days in the laser and sham groups. The mice in the laser group showed a significantly decreased thickness compared with the sham group at 10 and 12 days. Immunohistochemistry assay revealed that LLLT reduced inflammation and induced new lymphatic vessel growth. qPCR showed that expressions of VEGFR3 were (p = 0.002) increased in the laser group. These results suggest that LLLT has anti-inflammatory and lymphangiogenetic effects for the management of lymphedema.


Subject(s)
Low-Level Light Therapy , Lymphangiogenesis/radiation effects , Lymphedema/radiotherapy , Animals , Disease Models, Animal , Female , Gene Expression Regulation/radiation effects , Inflammation/radiotherapy , Lymphatic Vessels/physiopathology , Lymphatic Vessels/radiation effects , Lymphedema/genetics , Lymphedema/immunology , Lymphedema/physiopathology , Macrophage Activation/radiation effects , Mice , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, Vascular Endothelial Growth Factor/genetics , Regeneration/radiation effects , Vascular Endothelial Growth Factor A/genetics
8.
Environ Toxicol ; 31(8): 998-1008, 2016 Aug.
Article in English | MEDLINE | ID: mdl-25640594

ABSTRACT

Atrazine (ATR) is one of the most commonly applied broad-spectrum herbicides. Although ATR is well known to be a biologically hazardous molecule with potential toxicity in the immune system, the molecular mechanisms responsible for ATR-induced immunotoxicity remain unclear. In this study, we found that the immunotoxic properties of ATR were mediated through the induction of apoptotic changes in T lymphocytes. Mice exposed to ATR for 4 weeks exhibited a significant decrease in the number of spleen CD3(+) T lymphocytes, while CD19(+) B lymphocytes and nonlymphoid cells were unaffected. ATR exposure also led to inhibition of cell growth and induction of apoptosis in human Jurkat T-cells. Importantly, ATR triggered the activation of caspase-3 and the cleavage of caspase-8 and PARP, whereas it did not affect the release of cytochrome c from the mitochondria in Jurkat T-cells. In addition, ATR activated the unfolded protein response signaling pathway, as indicated by eIF2α phosphorylation and CHOP induction. Our results demonstrate that ATR elicited an immunotoxic effect by inducing ER stress-induced apoptosis in T-cells, therefore providing evidence for the molecular mechanism by which ATR induces dysregulation of the immune system. © 2015 Wiley Periodicals, Inc. Environ Toxicol 31: 998-1008, 2016.


Subject(s)
Apoptosis/drug effects , Atrazine/toxicity , Endoplasmic Reticulum Stress/drug effects , Herbicides/toxicity , Water Pollutants, Chemical/toxicity , Animals , Caspase 8/metabolism , Cytochromes c/metabolism , Humans , Jurkat Cells , Male , Mice , Mice, Inbred ICR , Mitochondria/metabolism , Signal Transduction/drug effects , Spleen/drug effects , Spleen/pathology , Unfolded Protein Response
9.
Arthritis Res Ther ; 17: 350, 2015 Dec 04.
Article in English | MEDLINE | ID: mdl-26634249

ABSTRACT

BACKGOUND: The formation of bony spurs and ankylosis is a key pathognomic feature in ankylosing spondylitis (AS) and results in functional impairment. The aim of this study was to investigate the role of IL-32γ in osteoblast (OB) differentiation and its association with the pathogenesis of AS. METHODS: The concentration and expression of IL-32γ were evaluated in synovial fluid and tissue from patients with AS, rheumatoid arthritis (RA) and osteoarthritis (OA), using enzyme-linked immunosorbent assay and immunohistochemistry. To establish whether IL-32γ affects OB differentiation, we used calvarial cells of IL-32γ transgenic (TG) mice or wild-type (WT) mice. To elucidate the mechanism of osteoblastogenesis, levels of regulators were assayed in IL-32γ TG mice and in primary OBs after IL-32γ stimulation. RESULTS: The IL-32γ levels were higher in the synovial fluid of AS patients compared with RA or OA patients and the expression of IL-32 was higher in AS synovia than in RA or OA synovia. Additional IL-32γ stimulation in precursor cells enhanced OB differentiation potentially and IL-32γ TG mice showed higher rates of OB differentiation than WT mice. IL-32γ reduced the expression of DKK-1, a negative regulator, in both WT precursor cells and human OBs and the constitutive expression of DKK-1 was suppressed in calvarial cells from IL-32γ TG mice. CONCLUSIONS: The elevated level of IL-32γ in AS joint could enhance OB differentiation via DKK-1 suppression. Therefore, IL-32γ might be a putative molecular target to prevent the abnormal bone formation in AS.


Subject(s)
Interleukins/metabolism , Osteoblasts/cytology , Spondylitis, Ankylosing/pathology , Animals , Blotting, Western , Cell Differentiation/physiology , Enzyme-Linked Immunosorbent Assay , Humans , Immunohistochemistry , Mice , Mice, Inbred C57BL , Mice, Transgenic , Osteoblasts/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Spondylitis, Ankylosing/metabolism , Synovial Fluid/metabolism , Synovial Membrane/metabolism
10.
Int J Biochem Cell Biol ; 54: 198-207, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25091703

ABSTRACT

Bone resorption by osteoclasts requires the release of secretory lysosomes containing cathepsin K, which degrades the organic bone matrix. The activity of this secretory function is determined by the level of lipidation of microtubule-associated protein 1 light chain 3 (LC3). Although the inflammatory cytokine IL-1ß increases osteoclast activity, the underlying mechanism(s) remains undefined. In our present study, we found that IL-1ß accelerates the release of cathepsin K from osteoclast precursors by increasing the cleavage and lipidation of LC3 and the subsequent formation of lipid-bound LC3-II containing secretory lysosomes. IL-1ß increased LC3-II formation within osteoclast precursors through a process that is dependent on increases in the intracellular Ca(2+) levels. In addition, IL-1ß was found to act synergistically with RANKL to increase ERK activation in a Ca(2+)-dependent manner. More importantly, Atg7-deficient osteoclast precursors, which showed impaired lipidation of LC3-I, did not exhibit IL-1ß-mediated increases in cathepsin K secretion. Thus, IL-1ß promotes LC3-II formation through the Ca(2+)-dependent activation of ERK, which triggers the release of cathepsin K. These findings provide evidence for a molecular mechanism through which IL-1ß enhances the secretory function of osteoclast precursors.


Subject(s)
Bone Marrow/metabolism , Calcium/metabolism , Cathepsin K/metabolism , Interleukin-1beta/pharmacology , Macrophages/metabolism , Microtubule-Associated Proteins/metabolism , Osteoclasts/metabolism , Animals , Blotting, Western , Bone Marrow/drug effects , Cell Differentiation/drug effects , Cells, Cultured , Macrophages/cytology , Macrophages/drug effects , Mice , Microtubule-Associated Proteins/antagonists & inhibitors , Microtubule-Associated Proteins/genetics , Osteoclasts/cytology , Osteoclasts/drug effects , RNA, Messenger/genetics , RNA, Small Interfering/genetics , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction
11.
Biochem Biophys Res Commun ; 450(1): 105-9, 2014 Jul 18.
Article in English | MEDLINE | ID: mdl-24866235

ABSTRACT

Secretory clusterin (sCLU)/apolipoprotein J is a multifunctional glycoprotein that is ubiquitously expressed in various tissues. Reduced sCLU in the joints of patients with bone erosive disease is associated with disease activity; however, its exact role has yet to be elucidated. Here, we report that CLU is expressed and secreted during osteoclastogenesis in mouse bone marrow-derived macrophages (BMMs) that are treated with receptor activator of nuclear factor kappa-B ligand (RANKL) and macrophage colony-stimulating factor (M-CSF). CLU-deficient BMMs obtained from CLU(-/-) mice exhibited no significant alterations in OC differentiation in comparison with BMMs obtained from wild-type mice. In contrast, exogenous sCLU treatment significantly inhibited OC formation in both BMMs and OC precursor cultures. The inhibitory effect of sCLU was more prominent in BMMs than OC precursor cultures. Interestingly, treating BMMs with sCLU decreased the proliferative effects elicited by M-CSF and suppressed M-CSF-induced ERK activation of OC precursor cells without causing apoptotic cell death. This study provides the first evidence that sCLU reduces OC formation by inhibiting the actions of M-CSF, thereby suggesting its protective role in bone erosion.


Subject(s)
Clusterin/metabolism , Macrophage Colony-Stimulating Factor/metabolism , Macrophages/physiology , Osteoclasts/cytology , Osteoclasts/physiology , Stem Cells/cytology , Stem Cells/physiology , Animals , Cell Differentiation , Cell Proliferation , Cells, Cultured , Macrophage Activation/physiology , Mice , Mice, Inbred C57BL
12.
J Cell Physiol ; 229(12): 1963-71, 2014 Dec.
Article in English | MEDLINE | ID: mdl-24733562

ABSTRACT

Beclin-1 plays a critical role in autophagy; however, it also contributes to other biological processes in a non-autophagic manner. Although studies have examined the non-autophagic role of autophagy proteins in the secretory function of osteoclasts (OC), the role of Beclin-1 is unclear. Here, we examined the role of Beclin-1 in OC differentiation, and found that mouse bone marrow macrophages (BMMs) showed increased expression of Beclin-1 upon RANKL stimulation in a p38- and NF-kappa B-dependent manner. During OC differentiation, Beclin-1 localized to the mitochondria, where it was involved in the production of mitochondrial intracellular reactive oxygen species. Knockdown of Beclin-1 in RANKL-primed BMMs led to a significant reduction in RANKL-dependent osteoclastogenesis, which was accompanied by reduced NFATc1 induction. Furthermore, knockdown of Beclin-1 inhibited RANKL-mediated activation of JNK and p38, both of which act downstream of reactive oxygen species, resulting in the suppression of NFATc1 induction. Finally, overexpression of constitutively active NFATc1 rescued the phenotype induced by Beclin-1 knockdown, indicating that Beclin-1 mediates RANKL-induced osteoclastogenesis by regulating NFATc1 expression. These findings show that Beclin-1 plays a non-autophagic role in RANKL-induced osteoclastogenesis by inducing the production of reactive oxygen species and NFATc1.


Subject(s)
Apoptosis Regulatory Proteins/biosynthesis , Cell Differentiation/genetics , Osteoclasts/cytology , RANK Ligand/biosynthesis , Animals , Apoptosis Regulatory Proteins/genetics , Apoptosis Regulatory Proteins/metabolism , Beclin-1 , Bone Marrow Cells/cytology , Cell Survival/genetics , Cells, Cultured , Gene Expression Regulation, Developmental , Humans , Macrophages/cytology , Mice , RANK Ligand/genetics , RANK Ligand/metabolism , RNA, Small Interfering
13.
J Cell Physiol ; 229(11): 1744-52, 2014 Nov.
Article in English | MEDLINE | ID: mdl-24664887

ABSTRACT

Pentraxin-3 (PTX3), also known as tumor necrosis factor-stimulated gene 14 (TSG-14), is produced by immune and vascular cells in response to pro-inflammatory signals and is therefore a multipotent inflammatory mediator. The present study showed that during human osteoblast (OB) differentiation, precursor OBs (pOBs), but not mature OB, highly expressed PTX3. TNFα treatment elevated the PTX3 expression of pOBs. When mice were injected with lipopolysaccharide, which induces an inflammatory osteolytic condition characterized by trabecular bone destruction and high osteoclastogenesis, their bone marrow cells expressed elevated levels of PTX3 protein. Exogenous PTX3 did not directly affect osteoclast (OC) or OB differentiation. However, when pOBs and precursor OCs were co-cultured, exogenous PTX3 significantly increased the number of tartrate-resistant acid phosphatase-positive multinucleated cells (i.e., OC cells) by increasing the pOB mRNA expression and protein secretion of RANK ligand (RANKL). This was accompanied with increased Runt-related transcription factor 2 (Runx2) expression in the pOBs. Knock-down of endogenous PTX3 with small-interfering RNA did not change the osteogenic potential of pOBs but suppressed their production of RANKL and reduced osteoclastogenesis. Finally, TNFα treatment of the co-culture elevated PTX3 expression by the pOBs and increased OC formation. This effect was suppressed by PTX3 knock-down by decreasing RANKL expression. Thus, the PTX3-driven increase in the osteoclastogenic potential of pOBs appears to be mediated by the effect of PTX3 on pOB RANKL production. These findings suggest that PTX3 is an inflammatory mediator that contributes to the deteriorating osteolytic condition of inflamed bone. J. Cell. Physiol. 229: 1744-1752, 2014. © 2014 Wiley Periodicals, Inc.


Subject(s)
C-Reactive Protein/metabolism , Nerve Tissue Proteins/metabolism , Osteoblasts/metabolism , Osteoclasts/metabolism , Osteogenesis , RANK Ligand/biosynthesis , Serum Amyloid P-Component/metabolism , Animals , Bone Marrow Cells/pathology , Cell Differentiation/drug effects , Coculture Techniques , Gene Knockdown Techniques , Humans , Inflammation/pathology , Mice , Mice, Inbred ICR , Osteoblasts/drug effects , Osteoblasts/pathology , Osteoclasts/drug effects , Osteoclasts/pathology , Osteogenesis/drug effects , Osteoprotegerin/metabolism , Solubility , Tumor Necrosis Factor-alpha/pharmacology
14.
Oncotarget ; 5(2): 481-92, 2014 Jan 30.
Article in English | MEDLINE | ID: mdl-24457902

ABSTRACT

Pentraxin 3 (PTX3), a modulator of tumor-associated inflammation, is known to be positively correlated with tumor grade and severity of malignancies, but its exact role remains unclear. This study found that PTX3 expression was up-regulated in distant bone metastases of breast cancer compared to lung, liver, and brain metastases in 64 human breast cancer patients. Elevated expression of PTX3 was correlated with poor survival in patients with breast cancer. PTX3 expression was also up-regulated in a bone metastatic breast cancer cell line and further enhanced by pro-inflammatory cytokine TNFα. Administration of PTX3 promoted the migratory potential of breast cancer cells and the mobilization of macrophages, a precursor of osteoclasts (OCs), toward breast cancer cells. In addition, elevated expression of PTX3 by TNFα led to enhanced OC formation, implying the distinct role of PTX3 in osteolytic bone metastasis of breast cancer cells. Furthermore, PTX3 silencing using PTX3-specific siRNA prevented breast cancer cell migration, macrophage chemotaxis, and subsequent OC formation. These findings provide an important insight into the key role of PTX3 in inflammation-associated osteolytic complications of breast cancer.


Subject(s)
Bone Neoplasms/metabolism , Bone Neoplasms/secondary , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , C-Reactive Protein/metabolism , Serum Amyloid P-Component/metabolism , Animals , Bone Neoplasms/genetics , Breast Neoplasms/genetics , C-Reactive Protein/biosynthesis , C-Reactive Protein/genetics , Cell Line, Tumor , Cell Movement/physiology , Female , Gene Expression Profiling , Humans , MCF-7 Cells , Mice , Mice, Transgenic , Osteoclasts/metabolism , Osteoclasts/pathology , Serum Amyloid P-Component/biosynthesis , Serum Amyloid P-Component/genetics , Transfection , Up-Regulation
15.
Angew Chem Int Ed Engl ; 52(9): 2534-7, 2013 Feb 25.
Article in English | MEDLINE | ID: mdl-23362232

ABSTRACT

A multistep enzyme catalysis was successfully implemented to produce long-chain α,ω-dicarboxylic and ω-hydroxycarboxylic acids from renewable fatty acids and plant oils. Sebacic acid as well as ω-hydroxynonanoic acid and ω-hydroxytridec-11-enoic acid were produced from oleic and ricinoleic acid.


Subject(s)
Dicarboxylic Acids/chemical synthesis , Fatty Acids/chemistry , Plant Oils/chemistry , Dicarboxylic Acids/analysis , Dicarboxylic Acids/chemistry , Mixed Function Oxygenases/chemistry , Mixed Function Oxygenases/metabolism , Pseudomonas fluorescens/enzymology
SELECTION OF CITATIONS
SEARCH DETAIL
...